In accordance with the proposal and results of the present study, patients who present with a pre-operative serum CEA level of twice the cut-off value or with a pre-operative bowel obstruction should be considered as candidates for adjuvant chemotherapy. The gene discussed is CEACAM5; the disease is intestinal obstruction.